C-Terminal Fragment, Aβ(39–42)-Based Tetrapeptides Mitigates Amyloid-β Aggregation-Induced Toxicity

[Image: see text] Since the introduction of acetyl cholinesterase inhibitors as the first approved drugs by the US Food and Drug Administration for Alzheimer’s disease (AD) in clinics, less than satisfactory success in the design of anti-AD agents has impelled the scientists to also focus toward inh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Omega
Main Authors: Bansal, Sunil, Maurya, Indresh Kumar, Yadav, Nitin, Thota, Chaitanya Kumar, Kumar, Vinod, Tikoo, Kulbhushan, Chauhan, Virander Singh, Jain, Rahul
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2018
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6645473/
https://ncbi.nlm.nih.gov/pubmed/31459130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.8b01522
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados